Mile­stone’s ar­rhyth­mia drug on track for Chi­na fil­ing with new Phase 3 da­ta

Mile­stone’s cal­ci­um chan­nel block­er suc­ceed­ed in a late-phase tri­al in Chi­na in peo­ple with an ab­nor­mal heart rhythm dis­or­der, sup­port­ing on­go­ing ef­forts for an ap­proval …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER